Funding Alert Vol. 30 No. 4 Alert # 3 - April 16, 2019

Texas Department of State Health Services icon Funding Information Center icon Toll free: 1-888-963-7111 ext. 7684 icon Austin phone: (512) 776-7684 icon Fax: (512) 776-7683


The Texas Department of State Health Services Funding Alert is published weekly.  If you wish to subscribe to the Funding Information Center Funding Alert and other services, please call (512) 776-7684 or fill out our online subscription form which can be found at: https://dshs.texas.gov/fic/subscribe.aspx.  Information in the Funding Alert is not copyrighted and may be reproduced. The Texas Department of State Health Services Funding Information Center would appreciate credit for the material used and a copy of the reprint. For information on viewing Adobe Acrobat .pdf and other files, see file viewing information.

Disclaimer: External links to other sites are intended to be informational and do not have the endorsement of the Department of State Health Services. These sites may also not be accessible to persons with disabilities. External e-mail links are provided to you as a courtesy. Please be advised that you are not e-mailing the Texas Department of State Health Services (DSHS) and DSHS policies do not apply should you choose to correspond.


Funding News and Grant Tips

Cancer Prevention and Research Institute of Texas Proposes Rule Changes, Now Taking Public Comments 
During their meeting on February 21, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) Oversight Committee approved release of proposed changes to current agency rules for public comment.
The proposed amendments affect Texas Administrative Code Chapter 703 related to due diligence review of Product Development Research applications, program specific audit requirements, and unallowable grantee expenses.
The proposed amendments were published in the March 29th edition of the Texas Register and are also available on the CPRIT website, which may be viewed at Proposed Changes to Texas Administrative Code Title 25, Chapter 703.
Written comments about the proposed rule changes should be submitted to CPRIT no later April 29, 2019. Written comments may be sent to Ms. Kristen Doyle, CPRIT’s General Counsel, by email (kdoyle@cprit.texas.gov); by fax (512-475-2563); or by mail addressed to the Cancer Prevention & Research Institute of Texas, P.O. Box 12097, Attn: Rulemaking Project, Austin, Texas, 78711.
From Cancer Prevention and Research Institute of Texas email, 4/4/19icon

U.S. Foundation Funding for LGBTQ Issues Total $185 Million in 2017
U.S. foundation funding to address gay, lesbian, bisexual, transgender, and queer issues totaled $185.7 million in 2017, a report from Funders for LGBTQ Issues finds.
According to the 2017 Tracking Report: Lesbian, Gay, Bisexual, Transgender and Queer Grantmaking by U.S. Foundations, the total was down from 2016, largely due to the more than $30 million distributed in response to the Pulse nightclub shooting that year, which pushed the amount given to a record $202.3 million. When grantmaking by the OneOrlando Fund is excluded, 2017 funding for LGBTQ issues increased by $10.8 million, or 6 percent, on a year-over-year basis. 
For the first time since the organization began tracking LGBTQ funding by region, the report found that the South received the most grant dollars, more than $22 million, a year-over-year increase of 27 percent. At the same time, foundation funding per capita for LGBTQ adults in the South — where more than a third of the country's LGBTQ adults live — lagged the Northeast and Pacific regions. The study also found that funding for trans communities in the United States reached a record high of $22.6 million in 2017, a 33 percent increase. 
According to the report, the top 10 funders of LGBTQ issues — led by the Arcus ($17 million), Ford ($12.4 million), Gill ($9.5 million), and Open Society ($7.8 million) foundations and Gilead Sciences ($11.7 million) — accounted for 43 percent of the total, or $86.2 million, up some $1.2 million from 2016 (excluding OneOrlando Fund grants). Private foundations awarded $93.4 million ($87.3 million, excluding funds for re-granting), up $4.7 million from the record high reported in 2016, with non-LGBTQ-focused private foundations accounting for $4.3 million of the increase. 
The study also found that the top 20 recipient organizations — which included the New York LGBT Center ($3.4 million), the Human Rights Campaign ($3.1 million), African Men for Sexual Health and Rights ($3 million) in South Africa, the Transgender Law Center ($2.86 million), and the Genders & Sexualities Alliance Network ($2.84 million) — received $40.4 million, accounting for 22 percent of the total. Non-LGBTQ-focused organizations received 35 percent of total grant dollars, the largest share since the study began tracking funding by organization type.
From The Foundation Center's Philanthropy News Digest by Candid email, 4/2/19icon


Public Funding Opportunities

Oral Health in People Living with HIV and Additional Non-Communicable Diseases (R01 Clinical Trial Not Allowed): RFA-DE-20-001 
SOURCE: National Institute of Dental and Craniofacial Research (NIDCR)
APPLICATION DEADLINE: Letter of Intent: 6/29/19. Application: 7/29/19 by 5 pm local time of applicant organization.
$ AVAILABLE: NIDCR intends to commit $2,500,000 in FY 2020 to fund three to four awards.
ELIGIBILITY: * Public/state/private controlled institutions of higher education.
* Hispanic-serving institutions.
* Historically Black Colleges and Universities (HBCUs).
* Tribally Controlled Colleges and Universities (TCCUs).
* Alaska native and native Hawaiian serving institutions.
* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
* Small businesses.
* For-profit organizations (other than small businesses).
* State governments.
* County governments.
* City or township governments.
* Special district governments.
* Indian/Native American tribal governments (federally recognized and other than federally recognized).
* Eligible agencies of the federal government.
* U.S. territories or possessions.
* Independent school districts.
* Public housing authorities/Indian housing authorities.
* Native American tribal organizations (other than federally recognized tribal governments).
* Faith-based or community-based organizations.
* Regional organizations.
* Non-domestic (non-U.S.) entities (foreign institutions).
PURPOSE: This Funding Opportunity Announcement (FOA) encourages research to address gaps in our knowledge of the oral health status of people living with HIV (PLWH) with an emphasis on PWLH who also have non-communicable diseases (NCDs). It supports efforts to understand the combined effects of HIV, antiretroviral therapy (ART), and NCDs on oral health, and it encourages identification of approaches for prevention and treatment of oral diseases and assessment of treatment outcomes in PLWH with or without NCDs. These efforts could help to generate evidence for oral health treatment guidelines tailored to the needs of dental patients with HIV.
CFDA: 93.121
CONTACT: Please see URL for multiple contacts. For more information see https://grants.nih.gov/grants/guide/rfa-files/RFA-DE-20-001.html
From CDC National Prevention Information Network's (NPIN) HIV/Hepatitis/STD/TB Funding Information email, 4/11/19icon 
Subject(s) dental health, HIV/AIDS services

Reducing the Duration of Untreated Psychosis in the United States (R34 Clinical Trial Required) (Reissue of PAR-18-232): PAR-19-235
SOURCE: National Institute of Mental Health (NIMH)
APPLICATION DEADLINE: 2/16, 6/16, 10/16 by 5 pm local time of applicant organization. Expires 5/8/22.
$ AVAILABLE: The NIMH intends to commit approximately $3 million in FY 2020 to fund between four and six awards submitted to this announcement and the companion announcement, PAR-19-236.
ELIGIBILITY: * Public/state/private controlled institutions of higher education.
* Hispanic-serving institutions.
* Historically Black Colleges and Universities (HBCUs).
* Tribally Controlled Colleges and Universities (TCCUs).
* Alaska native and native Hawaiian serving institutions.
* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
* Small businesses.
* For-profit organizations (other than small businesses).
* State governments.
* County governments.
* City or township governments.
* Special district governments.
* Indian/Native American tribal governments (federally recognized and other than federally recognized).
* Eligible agencies of the federal government.
* U.S. territories or possessions.
* Independent school districts.
* Public housing authorities/Indian housing authorities.
* Native American tribal organizations (other than federally recognized tribal governments).
* Faith-based or community-based organizations.
* Regional organizations.
PURPOSE: Approximately 100,000 adolescents and young adults in the United States experience a first episode of psychosis (FEP) every year. The early phase of psychotic illness is widely viewed as a critical opportunity for indicated prevention, and a chance to alter the downward trajectory and poor outcomes associated with schizophrenia and related psychotic disorders. Unfortunately, numerous studies find a substantial delay between the onset of psychotic symptoms and the initiation of FEP care; in the U.S. treatment is typically delayed between one and three years. Early identification of FEP, rapid referral to evidence-based Coordinated Specialty Care (CSC) for early psychosis, and effective engagement in CSC services are essential to shortening the duration of untreated psychosis (DUP) and pre-empting the functional deterioration common in psychotic disorders. The World Health Organization advocates reducing DUP to 3 months or less. Accordingly, this Funding Opportunity Announcement (FOA) seeks planning research project grant applications that (1) identify a baseline rate of DUP in community or institutional settings; (2) map referral pathways to CSC care, (3) identify bottlenecks and gaps in the pathway to CSC care, and (4) develop and pilot test feasible strategies for substantially reducing DUP among persons with FEP. Alternatively, applicants who have already completed significant developmental or pilot work in this area are encouraged to apply to the companion R01 announcement PAR-19-236. 
CFDA: 93.242
CONTACT: Please see URL for multiple contacts. For more information see https://grants.nih.gov/grants/guide/pa-files/PAR-19-235.html
From U.S. Department of Health and Human Services, Office of Minority Health FYI Weekly Health Resources email, 4/10/19icon 
Subject(s) medical research

Reducing the Duration of Untreated Psychosis in the United States (R01 Clinical Trial Required) (Reissue of PAR-18-233): PAR-19-236
SOURCE: National Institute of Mental Health (NIMH)
APPLICATION DEADLINE: 2/5, 6/5, 10/5 by 5 pm local time of applicant organization. Expires 5/8/22.
$ AVAILABLE: The NIMH intends to commit approximately $3 million in FY 2020 to fund between four and six awards submitted to this announcement and the companion announcement, PAR-19-235.
ELIGIBILITY: * Public/state/private controlled institutions of higher education.
* Hispanic-serving institutions.
* Historically Black Colleges and Universities (HBCUs).
* Tribally Controlled Colleges and Universities (TCCUs).
* Alaska native and native Hawaiian serving institutions.
* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
* Small businesses.
* For-profit organizations (other than small businesses).
* State governments.
* County governments.
* City or township governments.
* Special district governments.
* Indian/Native American tribal governments (federally recognized and other than federally recognized).
* Eligible agencies of the federal government.
* U.S. territories or possessions.
* Independent school districts.
* Public housing authorities/Indian housing authorities.
* Native American tribal organizations (other than federally recognized tribal governments).
* Faith-based or community-based organizations.
* Regional organizations.
PURPOSE: Approximately 100,000 adolescents and young adults in the United States experience a first episode of psychosis (FEP) every year. The early phase of psychotic illness is widely viewed as a critical opportunity for indicated prevention, and a chance to alter the downward trajectory and poor outcomes associated with schizophrenia and related psychotic disorders. Unfortunately, numerous studies find a substantial delay between the onset of psychotic symptoms and the initiation of FEP care; in the U.S. treatment is typically delayed between one and three years. Early identification of FEP, rapid referral to evidence-based Coordinated Specialty Care (CSC) for early psychosis, and effective engagement in CSC services are essential to shortening the duration of untreated psychosis (DUP) and pre-empting the functional deterioration common in psychotic disorders. The World Health Organization advocates reducing DUP to 3 months or less. Accordingly, this Funding Opportunity Announcement (FOA) seeks research project grant applications that test practical, reproducible strategies for substantially reducing DUP among persons with FEP in the U.S. by eliminating bottlenecks or closing gaps in the pathway to CSC services. Alternatively, applicants whose work in this area is at a developmental stage should consider applying to the companion R34 FOA PAR-19-235. 
CFDA: 93.242
CONTACT: Please see URL for multiple contacts. For more information see https://grants.nih.gov/grants/guide/pa-files/PAR-19-236.html
From U.S. Department of Health and Human Services, Office of Minority Health FYI Weekly Health Resources email, 4/10/19icon 
Subject(s) medical research

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) (Reissue of RFA-CA-18-011): RFA-CA-19-047 
SOURCE: National Cancer Institute (NCI)
APPLICATION DEADLINE: Letter of Intent: 7/9/19. Application: 8/9/19 by 5 pm local time of applicant organization.
$ AVAILABLE: The NCI intends to commit $12 million in FY 2020 to fund up to 10 awards.
ELIGIBILITY: Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity. 
PURPOSE: This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for cancer-relevant projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency. The purpose of this FOA is to facilitate the transition of SBIR or STTR Phase II projects to the commercialization stage. This FOA is expected to promote partnerships between Federally-funded SBIR or STTR Phase II awardees and third-party investors and/or strategic partners to facilitate and accelerate the capital-intensive steps that are required to commercialize new products and services. Applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the Phase IIB Bridge Award project period. It is expected that the level of this independent third-party funding will be equal to or greater than the NCI funds being requested throughout the Phase IIB Bridge Award project period. Proposed projects may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate but are not required. 
CFDA: 93.394, 93.395 
CONTACT: Please see URL for multiple contacts. For more information see https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-047.html
From NIH web site, accessed 4/11/19icon
Subject(s) cancer research, technology

Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed): RFA-DA-19-039
SOURCE: National Institute on Drug Abuse (NIDA)
APPLICATION DEADLINE: Letter of Intent: 4/24/19. Application: 5/24/19 by 5 pm local time of applicant organization.
$ AVAILABLE: NIDA intends to commit $3 million in FY 2019 to fund six awards.
ELIGIBILITY: * Public/state/private controlled institutions of higher education.
* Hispanic-serving institutions.
* Historically Black Colleges and Universities (HBCUs).
* Tribally Controlled Colleges and Universities (TCCUs).
* Alaska native and native Hawaiian serving institutions.
* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
* Small businesses.
* For-profit organizations (other than small businesses).
* State governments.
* County governments.
* City or township governments.
* Special district governments.
* Indian/Native American tribal governments (federally recognized and other than federally recognized).
* Eligible agencies of the federal government.
* U.S. territories or possessions.
* Independent school districts.
* Public housing authorities/Indian housing authorities.
* Native American tribal organizations (other than federally recognized tribal governments).
* Faith-based or community-based organizations.
* Regional organizations.
* Non-domestic (non-U.S.) entities (foreign institutions).
PURPOSE: The scientific objective of this Funding Opportunity Announcement (FOA) is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat neuroinflammation and immune dysregulation aroused in these processes.
CFDA: 93.279
CONTACT: Please see URL for multiple contacts. For more information see https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-039.html
From CDC National Prevention Information Network's (NPIN) HIV/Hepatitis/STD/TB Funding Information email, 4/11/19icon 
Subject(s) HIV/AIDS research, substance abuse research


Private Funding Opportunities

AACR-MPM Invites Letters of Intent for Transformative Cancer Research
SOURCE: American Association for Cancer Research, MPM Capital
APPLICATION DEADLINE: Letters of intent are due by 5/10/19. Upon review, selected applicants will be invited to submit a complete proposal by 8/8/19.
$ AVAILABLE: Grants of up to $400,000 over two years will be awarded for any type of basic, translation, or clinical research.
ELIGIBILITY: To be eligible for a grant, applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree; hold an appointment at the level of assistant or associate professor by the start of the grant term (November 1, 2019); and be an AACR member in good standing.
PURPOSE: The American Association for Cancer Research, in partnership with healthcare investment firm MPM Capital, is inviting Letters of Intent for its Oncology Charitable Foundation Transformative Cancer Research Grants program. 
A new funding initiative, the program is intended to stimulate high-risk, high-reward research by early- to mid-career investigators and promote and support creative, paradigm-shifting cancer research that might not be funded through conventional channels. It is expected that grants awarded through the program will catalyze significant scientific discoveries that advance understanding of cancer and have a potentially transformative impact on future clinical practice.
CONTACT: Please see URL for contact information. For more information see https://www.aacr.org/Funding/Pages/Funding-Detail.aspx?ItemID=90
From The Foundation Center's Philanthropy News Digest RFP Bulletin email, 4/5/19icon
Subject(s) cancer research

American College of Psychiatrists Invites Nominations for Distinguished Service in Psychiatry Award
SOURCE: American College of Psychiatrists (ACP)
APPLICATION DEADLINE: 6/30/19.
$ AVAILABLE: The recipient of the award will receive travel, hotel, and free registration at ACP’s annual meeting as well as a gold medallion and certificate.
ELIGIBILITY: Please see URL for eligibility information.
PURPOSE: Comprising more than seven hundred and fifty psychiatrists who have demonstrated excellence in the field of psychiatry and achieved national recognition in clinical practice, research, academic leadership, or teaching, the American College of Psychiatrists works to promote the highest standards in psychiatry.
To help advance this mission, ACP is currently inviting applications for its Distinguished Service in Psychiatry Award, which recognizes significant achievement and leadership in the field.
CONTACT: Please see URL for contact information. For more information see https://www.acpsych.org/awards/distinguished-service-award-nominations-deadline-june-30
From The Foundation Center's Philanthropy News Digest RFP Bulletin email, 4/5/19icon
Subject(s) medical research

Brookdale Foundation Issues RFP for Relatives as Parents Program
SOURCE: Brookdale Foundation 
APPLICATION DEADLINE: 6/12/19
$ AVAILABLE: Up to fifteen programs will receive seed grants of up to $15,000. 
ELIGIBILITY: To be eligible, applicants must be considered tax exempt under section(c)(3) of the Internal Revenue Code.
PURPOSE: The Brookdale Foundation is accepting applications for its Relatives as Parents program.
Established in 1996, the program aims to develop or expand services for grandparents or other relatives who have taken on the responsibility of surrogate parenting when the biological parents are unable to do so.
Through the program, up to fifteen programs will receive seed grants of up to $15,000 to start a new program or expand current services in response to caregiver needs. Services and assistance to relative caregivers and the children in their care must include regular ongoing support, educational or social groups, and at least two of the following: benefits and legal guidance, educational seminars, individual and/or family counseling, health care services, childcare, housing assistance, children’s services, group recreational activities, transportation assistance, services to special populations, services with local schools, or mental health services.
Through the program, the foundation will also provide ongoing technical assistance to recipients.
Selected applicants will be required to attend, as a guest of the foundation, an orientation and training conference, October 24-26, 2019, in Teaneck, New Jersey.
CONTACT: Please see URL for contact information. For more information see http://www.brookdalefoundation.org/
From The Foundation Center's Philanthropy News Digest RFP Bulletin email, 4/5/19icon
Subject(s) caregiver assistance

Chorodoma Foundation Accepting Applications for Clinical Trials
SOURCE: Chorodoma Foundation 
APPLICATION DEADLINE: Concept papers are due by 5/10/19. Upon review, selected candidates will be invited to submit a full trial protocol and budget.
$ AVAILABLE: Mechanisms of support offered through this RFP include trial initiation assistance and patient education and outreach, with grants of up to $300,000 awarded to fund non-drug study costs of investigator-initiated trials. 
ELIGIBILITY: Eligible applicants include investigators at academic institutions, nonprofit research institutions, and for-profit companies.
PURPOSE: The Chorodoma Foundation is accepting applications for its Clinical Trials program.
Through the program, the foundation seeks to eliminate the barriers that typically hinder clinical trials for rare cancers, ensuring that scientifically-sound treatment approaches are tested in chorodoma patients as quickly as possible. Under this RFP, the foundation aims to identify one or more new therapeutic concepts with strong scientific rationale. Awards will be given in support of well-justified clinical trials designed to determine whether, and to what extent, promising new therapies can improve the lives of chorodoma patients.
CONTACT: Please see URL for contact information. For more information see https://www.chordomafoundation.org/wp-content/uploads/2019/03/Clinical-Trials-Program-RFP-2019.pdf
From The Foundation Center's Philanthropy News Digest web site, accessed 4/11/19icon
Subject(s) medical research

Cystic Fibrosis Foundation Accepting Applications for Pilot and Feasibility Awards
SOURCE: Cystic Fibrosis Foundation 
APPLICATION DEADLINE: 5/13/19.
$ AVAILABLE: Grants of up to $50,000 a year for up to two years will be awarded through the program.
ELIGIBILITY: To be eligible, applicants must be an independent investigator. Both U.S. and non-U.S. residents are welcome to apply. International applicants and institutions are required to submit additional information in accordance with USA Patriot Act and the U.S. Department of Treasury Anti-Terrorist Financing Guidelines.
PURPOSE: The Cystic Fibrosis Foundation works to mobilize scientists, caregivers, donors, and volunteers to provide those with the disease the opportunity to lead full, productive lives.
To that end, the foundation is accepting applications for its Pilot and Feasibility Awards program. Through the program, grants are awarded to investigators working to develop and test new hypotheses and/or methods that address problems related to cystic fibrosis, and/or to promising new investigators as they establish themselves in research areas relevant to CF. Only basic science research is supported under the program, and it is hoped that information derived from the funded studies will lead to submission to other funding agencies (such as the National Institutes of Health). Proposed work must be hypothesis-driven and reflect innovative approaches to critical questions in cystic fibrosis research.
Priorities identified by the foundation include molecular characterization of CFTR mutations other than F508del; direct and indirect influences of CFTR modulation on the airway milieu, including resident pathogens, inflammation and inflammatory cell function, mucin structure (tethered and secreted), airway surface liquid (ASL), and mucociliary clearance (MCC); novel means for restoring CFTR function; mechanisms associated with nonsense mutations and means to overcome them, specifically mRNA stability and translational regulation; biological mechanisms involved in lung allograft dysfunction/rejection and transplant immunology; improved understanding of acquisition, pathogenesis, host-pathogen interactions, and treatment approaches for difficult to treat CF infections (i.e., NTM, MDR Pseudomonas, MRSA, Aspergillus); approaches to understanding and treating CF related GI complications and the impact of nutritional deficiencies; and the effects of endocrine system dysfunction in CF, including Cystic Fibrosis Related Diabetes (CFRD).
CONTACT: Please see URL for contact information. For more information see https://www.cff.org/Research/Researcher-Resources/Awards-and-Grants/Research-Awards/Pilot-and-Feasibility-Policies-and-Guidelines.pdf
From The Foundation Center's Philanthropy News Digest web site, accessed 4/11/19icon
Subject(s) medical research

Cystic Fibrosis Foundation Accepting Applications for Postdoctoral Research Fellowship Awards
SOURCE: Cystic Fibrosis Foundation 
APPLICATION DEADLINE: 5/13/19.
$ AVAILABLE: Fellows will receive salary support of up to $50,000, with an additional $8,850 for expenses in year one, and up to $52,000 with an additional $9,200 in year two. Research and travel expenses of up to $4,250 also are available for each year of the award.
ELIGIBILITY: To be eligible, applicants must be a citizen or permanent resident of the United States, or a non-resident working in a U.S.-based lab.
PURPOSE: The Cystic Fibrosis Foundation’s Postdoctoral Research Fellowship Award program supports the training of postdocs in new research areas and methods related to CF as well as the collection of data that can be sued to enable their transition into an independent research career. Research projects proposed through the program should seek to develop new information that contributes to the understanding and basic etiology and pathogenesis of cystic fibrosis. Preference will be given to recent graduates and those just beginning their research careers.
Fellowship awards may be approved for up to a two-year period, with funding for year two contingent on submission and approval of a renewal progress report and the availability of funds. 
CONTACT: Please see URL for contact information. For more information see https://www.cff.org/Our-Research/For-Researchers/Training-Awards/Postdoctoral-Research-Fellowship-Policies-and-Guidelines.pdf
From The Foundation Center's Philanthropy News Digest web site, accessed 4/11/19icon
Subject(s) medical research

Harvard Law School Food Law and Policy Clinic Invites Technical Assistance Proposals for Sugar Reduction Activities
SOURCE: Harvard Law School Food Law and Policy Clinic (FLPC) 
APPLICATION DEADLINE: 5/1/19.
$ AVAILABLE: Please see URL for funding information.
ELIGIBILITY: Eligible candidates include community-based organizations; local, regional, or state food policy councils; and local or state government entities.
PURPOSE: The Harvard Law School Food Law and Policy Clinic, with support from Arnold Ventures, is launching a new initiative to identify locally-supported policies that help reduce sugar consumption in the general population and build capacity for change at the policy level.
To that end, FLPC is accepting proposals for technical assistance from community organizations, food policy councils, and local, state, and tribal government entities interested in implementing innovative sugar-reduction policies.
Through the initiative, two organizations will receive a year of in-depth capacity-building engagement that includes nonpartisan research and legal consultation as well as resources on a variety of sugar-reduction policies tailored to the interests of the grantee; early-stage coalition building and community outreach support; and communications materials and media outreach.
CONTACT: Please see URL for contact information. For more information see https://www.chlpi.org/wp-content/uploads/2013/12/FLPC-Request-for-Technical-Assistance-Proposals-Sugar-Reduction-3-5-19.pdf
From The Foundation Center's Philanthropy News Digest RFP Bulletin email, 4/5/19icon
Subject(s) health promotion/wellness, nutrition/food service

One Mind Accepting Applications for Rising Star Research Awards
SOURCE: One Mind 
APPLICATION DEADLINE: 5/15/19.
$ AVAILABLE: Up to five award recipients will receive $250,000 over three years. In addition, up to three supplemental technology grants will be awarded, with each including a state of the art nVoke miniature microscope system, full scientific support, and full technical support. Applicants may apply for the technology grant only as a supplement to a Rising Star Award proposal and cannot apply for the technology grant by itself.
ELIGIBILITY: To be eligible, candidates should be within 10 years of their initial independent appointment and have demonstrated productivity and innovation in a scientific field that can be applied to the study of neuropsychiatric disorders such as attention-deficit hyperactivity disorder (ADHD), anxiety, addiction, bipolar disorder, depression, post-traumatic stress, schizophrenia, traumatic brain injury, digital therapies, or other field relevant to brain health.
PURPOSE: With the goal of accelerating research on major neuropsychiatric disorders, One Mind, in partnership with Janssen Research & Development, Otsuka Pharmaceuticals, Kaiser Permanente, the Gifford Foundation, and Bettina Bryant, is accepting applications for its Rising Star Research Awards, which recognizes and funds promising, early-career investigators.
The program seeks to fund research directed at understanding the fundamental characteristics and biological mechanisms of brain function and disfunction, as well as the translation of basic science mechanisms into better diagnostics and treatments for neuropsychiatric disorders. Of particular interest is research dedicated to schizophrenia and/or depression. Studies that use exiting data and collaborations to accelerate discovery and knowledge also are encouraged.
Examples of relevant research through this opportunity include but are not limited to studies focused on the biological mechanisms of neuropsychiatric and/or neurotraumatic disorder(s); the identification of pharmacological and non-pharmacological therapeutic targets; the development of new or refinement of existing models for studying neuropsychiatric and/or nearotraumatic disorders; the development of new or improvement of existing tools for studying brain health; the identification or advancement of biomarker development for neuropsychiatric disorder(s); the development of targeted therapies to prevent the onset or progression of neuropsychiatric disorders, mitigate their negative effects on brain function and behavior, and/or promote recovery; the characterization of similarities and differences in biological mechanisms between two or more neuropsychiatric disorders, and/or characterization of the effects of comorbid conditions on diagnosis, prognosis, and treatments; the external validation of promising biomarkers, diagnostic tools, and treatments; a comparison of the effects of treatments on whole or select patient populations; and the generation of new hypotheses from existing clinical data and their testing in relevant preclinical or computational models, or in small pilot clinical studies.
Applicants whose proposals can be enhanced with optical methods to investigate links between neural circuit/ensemble dynamics and disease phenotypes are encouraged to apply for a supplemental technology grant from Inscopix. Proposals within this category might include but are not limited to signal analysis in health vs. disease, and/or how circuit/ensemble signatures change and evolve during disease progression and in therapeutic intervention paradigms; studies that use established or new rodent models of neuropsychiatric disorders to extract key characteristics of the pathophysiology in a cell type- and/or circuit-specific manner; and investigations into the causal role of disease circuit/ensemble dynamics identified with nVoke/nVista and potentially in conjunction with other methods such as pharmacology, chemogenetics, electrophysiology, and cell ablation.
CONTACT: Please see URL for contact information. For more information see https://onemind.org/wp-content/uploads/2019/03/2019-One-Mind-Rising-Star-Research-Awards-RFP.pdf
From The Foundation Center's Philanthropy News Digest web site, accessed 4/11/19icon
Subject(s) medical research

When Everyone Survives Foundation Accepting Applications for Innovative Leukemia Research
SOURCE: When Everyone Survives Foundation 
APPLICATION DEADLINE: 6/1/19.
$ AVAILABLE: One-year grants of up to $50,000. 
ELIGIBILITY: Please see URL for eligibility information.
PURPOSE: The When Everyone Survives Leukemia Research Foundation was established by the Smith family after their twenty-two-year-old son, Wes, succumbed to leukemia in 2005. The WES Foundation works to advance new, innovative research on treatments and a cure for leukemia.
To that end, one-year grants of up to $50,000 will be awarded to new and established investigators for laboratory, translational, or clinical research related to acute leukemia. Renewal of initial research support may be considered for one or more additional years based on productivity.
Interested investigators should submit a proposal of no more than five pages as a single document (scanned or saved as a PDF file) via email.
CONTACT: Please see URL for contact information. For more information see https://www.wheneveryonesurvives.org/grant_application
From The Foundation Center's Philanthropy News Digest web site, accessed 4/11/19icon
Subject(s) cancer research


Events

To Be or Not to Be a 501(c)(3) 
SPONSOR: San Antonio Area Foundation
WHEN: April 25, noon to 2 pm.
WHERE: San Antonio Area Foundation, 303 Pearl Parkway, Suite 114, (San Antonio, TX).
DESCRIPTION: Join us at this workshop if you are thinking about starting a 501(c)(3) nonprofit organization. 
Individuals see needs within their communities, and they decide to start a tax-exempt organization to deliver programs and services to meet those needs. This workshop will cover the basic research needed to start a nonprofit. 
Class objectives: 
* To learn the process for establishing a tax-exempt organization,
* To discuss the preparation work prior to applying to the IRS for tax-exempt status, and
* To explore the work needed to start up a tax-exempt organization.
COST: $25. For more information and registration go to http://saafdn.org/Nonprofits/WorkshopsLearning/EventsCalendar/tabid/174/
modId/618/key/EventDetail/start/636917904000000000/eventid/625/Default.aspx

CONTACT: San Antonio Area Foundation, (210) 225-2243. 
From San Antonio Area Foundation web site, accessed 4/11/19icon

Finding Funders Library Training 
SPONSOR: San Antonio Area Foundation
WHEN: April 25, 2 to 3:30 pm.
WHERE: San Antonio Area Foundation, 303 Pearl Parkway, Suite 114, (San Antonio, TX).
DESCRIPTION: The San Antonio Area Foundation will host a FREE library training workshop. This introductory session will be led by Kathy McDonald who will share important information about finding grants as well as highlight the electronic and print resources available for your free use at the San Antonio Area Foundation, a partner in the Foundation Center’s Funding Information Network. Participants are encouraged to bring tablets or laptops to search the Directory during the workshop. 
The Foundation Directory has a new look as of October 2017 - previous attendees are encouraged to return to learn how to search for funders using the new interface. 
COST: Free but registration is required. For more information and registration go to http://saafdn.org/Nonprofits/WorkshopsLearning/EventsCalendar/tabid/174/modId/618
/key/EventDetail/start/636917976000000000/eventid/635/Default.aspx

CONTACT: San Antonio Area Foundation, (210) 225-2243. 
From San Antonio Area Foundation web site, accessed 4/11/19icon

Advanced Grant Writing 
SPONSOR: San Antonio Area Foundation
WHEN: April 30, 9 am to 3 pm.
WHERE: San Antonio Area Foundation, 303 Pearl Parkway, Suite 114, (San Antonio, TX).
DESCRIPTION: Join us to learn advanced components of grant writing.
Learning Objectives:
* Read and interpret application guidelines;
* Identify data resources in developing compelling case statements;
* Conduct literature reviews and citations;
* Register and apply for federal and state funding via online submission;
* Develop a time line for grant submission;
* Understand and effectively write key elements of a federal proposal;
* Conduct a community needs assessment;
* Develop realistic budgets;
* Write project abstracts and narratives;
* Develop logic models
* Understand how federal grants are scored;
* Build your application online;
* Avoid pitfalls of federal grant writing.
COST: $125. For more information and registration go to http://saafdn.org/Nonprofits/WorkshopsLearning/EventsCalendar/tabid/174/
modId/618/key/EventDetail/start/636922116000000000/eventid/597/Default.aspx

CONTACT: San Antonio Area Foundation, (210) 225-2243. 
From San Antonio Area Foundation web site, accessed 4/11/19icon

Grant Management Techniques
SPONSOR: San Antonio Area Foundation
WHEN: May 1, 9 am to noon.
WHERE: San Antonio Area Foundation, 303 Pearl Parkway, Suite 114, (San Antonio, TX).
DESCRIPTION: This workshop will help you understand the entire grant cycle - from concept to closeout.
Successful grants management is one of the greatest challenges in the nonprofit world. In this workshop you will learn tips on how to satisfy your funders as you accomplish your program objectives. The program will also review sample grant monitoring systems.
Learning Objectives:
* Understanding the roles and responsibilities of actors in the grants management process.
* Current trends in the grant world.
* Sources of income and contracts.
* Grant monitoring systems.
* Internal management controls.
* Financial management controls.
* Process and outcome evaluations techniques.
* Understanding how funders monitor grants.
* Grant management tips and strategies for different grant sources.
* Grant management resources on the web.
COST: $60. For more information and registration go to http://saafdn.org/Nonprofits/WorkshopsLearning/EventsCalendar/tabid/174
/modId/618/key/EventDetail/start/636922980000000000/eventid/598/Default.aspx

CONTACT: San Antonio Area Foundation, (210) 225-2243. 
From San Antonio Area Foundation web site, accessed 4/11/19icon


returnReturn to Alert

Last updated April 16, 2019